All In Biotech

Drug Trial Radar · NCT01644877

A Phase II, Randomized, Double-blind, Placebo-controlled Study to Examine the Effects of DAS181 in Immunocompromised Subjects With Lower Respiratory Tract Parainfluenza Infection on Supplemental Oxygen

Last checked: Nov 19, 2026Latest source record: Sep 25, 2017 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 111 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

111

Actual

Start

Mar 2014

Primary completion

Dec 15, 2016

Study completion Dec 15, 2016

Sponsor

Lead sponsor
Ansun Biopharma, Inc.Industry
Sponsor type
Industry
First posted
Jul 19, 2012

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
Who can join
All sexes, from 12 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This protocol will seek to enroll immunocompromised patients who are on supplemental oxygen and diagnosed with a parainfluenza infection.

Conditions

  • Parainfluenza

Interventions

  • DAS181 dry powder, formulation F02Drug

  • Lactose PlaceboDrug

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Clinical StabilityTime frame: 45 days

Locations

45 sites in 1 country. Site status is shown where the registry gives one.

  • Mayo Clinic-Arizona

    Phoenix, Arizona

  • City of Hope

    Duarte, California

  • Children's Hospital of Orange County

    Orange, California

  • Stanford University Medical Center

    Palo Alto, California

  • UC Davis

    Sacramento, California

  • Ansun Biopharma, Inc

    San Diego, California

  • Children's Hospital Colorado

    Aurora, Colorado

  • Lurie Children's Hospital

    Chicago, Illinois

  • University of Chicago

    Chicago, Illinois

  • Loyola University Medical Center

    Maywood, Illinois

  • Indiana Blood and Marrow Transplantation

    Indianapolis, Indiana

  • University of Iowa

    Iowa City, Iowa

  • Children's Mercy Hospital

    Kansas City, Kansas

  • University of Kansas

    Kansas City, Kansas

  • John Hopkins University School of Medicine

    Baltimore, Maryland

  • Beth Israel Deaconess Medical Center

    Boston, Massachusetts

  • Brigham & Women's Hospital

    Boston, Massachusetts

  • University of Michigan

    Ann Arbor, Michigan

  • University of Minnesota, School of Medicine

    Minnesota City, Minnesota

  • Washington University School of Medicine

    St Louis, Missouri

  • Hackensack University Medical Center

    Hackensack, New Jersey

  • Weill Cornell Medical College/New York Presbyterian Hospital

    New York, New York

  • Weill Cornell Medical College-Peds

    New York, New York

  • University of Rochester Medical Center

    Rochester, New York

  • Stonybrook

    Stony Brook, New York

  • Montefiore Medical Center

    The Bronx, New York

  • Duke University Medical Center

    Durham, North Carolina

  • Cincinnati Children's Hospital

    Cincinnati, Ohio

  • Cleveland Clinic

    Cleveland, Ohio

  • Nationwide Children's

    Columbus, Ohio

  • University of Oklahoma

    Oklahoma City, Oklahoma

  • Children's Hospital of Philadelphia

    Philadelphia, Pennsylvania

  • Hospital of the University of Pennsylvania

    Philadelphia, Pennsylvania

  • University of Pittsburgh Medical Center

    Pittsburgh, Pennsylvania

  • Medical University of South Carolina

    Charleston, South Carolina

  • St. Jude Children's Research Hospital

    Memphis, Tennessee

  • Vanderbilt- Henry-Joyce Cancer Clinic

    Nashville, Tennessee

  • Baylor College of Medicine

    Houston, Texas

  • Texas Children's Hospital

    Houston, Texas

  • The University of Texas MD Anderson Cancer Center

    Houston, Texas

Showing 40 of 45 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.